Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Change in Receivables (2020 - 2023)

Pliant Therapeutics has reported Change in Receivables over the past 4 years, most recently at -$1.6 million for Q3 2023.

  • Quarterly Change in Receivables rose 54.95% to -$1.6 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$1.6 million through Jun 2024, up 53.65% year-over-year, with the annual reading at -$2.0 million for FY2023, 13120.0% down from the prior year.
  • Change in Receivables was -$1.6 million for Q3 2023 at Pliant Therapeutics, up from -$1.7 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $24.7 million in Q1 2020 and troughed at -$28.2 million in Q2 2020.
  • The 4-year median for Change in Receivables is -$220000.0 (2021), against an average of -$470133.3.
  • The largest YoY upside for Change in Receivables was 1187.21% in 2022 against a maximum downside of 1494.09% in 2022.
  • A 4-year view of Change in Receivables shows it stood at $2.1 million in 2020, then tumbled by 81.94% to $388000.0 in 2021, then grew by 29.12% to $501000.0 in 2022, then plummeted by 415.37% to -$1.6 million in 2023.
  • Per Business Quant, the three most recent readings for PLRX's Change in Receivables are -$1.6 million (Q3 2023), -$1.7 million (Q2 2023), and $1.3 million (Q1 2023).